Artwork
iconShare
 
Manage episode 486683357 series 3656761
Content provided by AdvisorShares. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by AdvisorShares or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Catch this AlphaNooner replay featuring Doug Drysdale, CEO of Cybin ($CYBN). Doug dives into Cybin's latest progress on psychedelic therapeutics, including key updates on CYB003 and CYB004, insights into the evolving biotech landscape, and why he's optimistic about the future of mental health treatments.

  continue reading

6 episodes